GABELLI & Co INVESTMENT ADVISERS, INC.
Source: SEC Form 13F · as of Mar 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds 18 biotech & pharma companies tracked by BioSniper, totaling $60.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$60.7M
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 152,400 | $17.5M |
| FOLDAMICUS THERAPEUTICS, INC. | 777,340 | $11.2M |
| TERNTerns Pharmaceuticals, Inc. | 205,700 | $10.8M |
| APLSApellis Pharmaceuticals, Inc. | 200,600 | $8.1M |
| DAWNDay One Biopharmaceuticals, Inc. | 325,350 | $7.0M |
| RVMDREVOLUTION MEDICINES, INC. | 13,400 | $1.3M |
| CYTKCYTOKINETICS INC | 13,578 | $895K |
| PFEPFIZER INC | 25,000 | $702K |
| GRFSGrifols S.A. | 77,728 | $623K |
| CNTACentessa Pharmaceuticals plc | 9,400 | $373K |
| TEVATeva Pharmaceutical Industries Limited | 12,000 | $361K |
| BBIOBridgeBio Pharma, Inc. | 4,500 | $334K |
| MRKMerck & Co., Inc. | 2,700 | $325K |
| LLYELI LILLY & Co | 350 | $322K |
| ABBVAbbVie Inc. | 1,350 | $294K |
| GILDGILEAD SCIENCES, INC. | 2,000 | $279K |
| JNJJOHNSON & JOHNSON | 1,000 | $244K |
| CTMXCytomX Therapeutics, Inc. | 11,000 | $52K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.